Market Cap | ₹7,713Cr |
ROE | 15.43% |
P/E Ratio(TTM) | 22.02 |
EPS(TTM) | 7.73 |
P/B Ratio | 3.13 |
Dividend Yield | 0.47% |
Industry P/E | 35.19 |
Book Value | 54.44 |
Debt to Equity | 0.13 |
Face Value | 1 |
Parent Organisation | Marksans Pharma Limited |
Managing Director | Mr. Mark Saldanha |
NSE Symbol | MARKSANS |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 61.10 | ||
Gland Pharma | NA (0.00%) | 42.27 | ||
Ajanta Pharma | NA (0.00%) | 33.99 | ||
Eris Lifesciences | NA (0.00%) | 57.15 |